AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 85 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $85,000 | +3.7% | 36,787 | +243.7% | 0.00% | – |
| Q3 2019 | $82,000 | -42.7% | 10,704 | -48.9% | 0.00% | – |
| Q2 2019 | $143,000 | -37.3% | 20,947 | -26.0% | 0.00% | – |
| Q1 2019 | $228,000 | +7.5% | 28,297 | 0.0% | 0.00% | – |
| Q4 2018 | $212,000 | -21.8% | 28,297 | 0.0% | 0.00% | – |
| Q3 2018 | $271,000 | +28.4% | 28,297 | +42.0% | 0.00% | – |
| Q2 2018 | $211,000 | – | 19,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 20,592 | $347,798 | 24.67% |
| VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
| IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |